Metraipolis › archive › dc_97002ea9d167

Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study — Europe PMC PMID:42821569

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42821569
DOI
10.1371/journal.pone.0357898
License (as archived)
solo-consultazione
Archived
2026-10-07T12:19:02.962Z
SHA-256 of the archived text
d8f72ba0b27bee043b5968cceff30446ca335c7a498c28a8bdafb19d8f4df18b
Stable URL of this page
https://metraipolis.com/documento/dc_97002ea9d167

How to cite

Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study — Europe PMC PMID:42821569 — Europe PMC (en), https://europepmc.org/article/MED/42821569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97002ea9d167 (Metraipolis archive dc_97002ea9d167, sha256 d8f72ba0b27bee043b5968cceff30446ca335c7a498c28a8bdafb19d8f4df18b)
BibTeX
@misc{dc97002ea9d167,
  title = {Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study — Europe PMC PMID:42821569},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42821569},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97002ea9d167; sha256 d8f72ba0b27bee043b5968cceff30446ca335c7a498c28a8bdafb19d8f4df18b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42821569. Agents can read the archived copy with the MCP tool read_document.